IL-1 Contributes to the Anti-Cancer Efficacy of Ingenol Mebutate

Ingenol mebutate is approved for the topical treatment of actinic keratoses and may ultimately also find utility in treating skin cancers. Here we show that relapse rates of subcutaneous B16 melanoma tumours treated topically with ingenol mebutate were not significantly different in C57BL/6 and Rag1...

Descripción completa

Detalles Bibliográficos
Autores principales: Le, Thuy T., Skak, Kresten, Schroder, Kate, Schroder, Wayne A., Boyle, Glen M., Pierce, Carly J., Suhrbier, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839727/
https://www.ncbi.nlm.nih.gov/pubmed/27100888
http://dx.doi.org/10.1371/journal.pone.0153975

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839727/
https://www.ncbi.nlm.nih.gov/pubmed/27100888
http://dx.doi.org/10.1371/journal.pone.0153975

Ejemplares similares